Processa Pharmaceuticals, Inc. (PCSA) NASDAQ

0.43

-0.0135(-3.02%)

Updated at March 14 01:44PM

Currency In USD

Valuation

Market Cap8.77M
Enterprise Value4.21M
P/E Ratio-0.12
PEG Ratio-0.01
Price/Sales Ratio0
Price/Book Ratio0.38
Enterprise/Revenue0
Enterprise/EBITDA0.06

Fiscal Year

Fiscal YearDecember 31, 2023
Most Recent QuarterSeptember 30, 2024

Profitability

Profit Margin0
Operating Margin0

Management Effectiveness

Return On Assets-2.33
Return On Equity-1.95

Income Statement

Revenue0
Revenue/Share0
Gross Profit-222
EBITDA-11.46M
Net Income-11.12M
Diluted EPS-8.48

Balance Sheet

Total Cash2.89M
Total Cash/Share0.88
Total Debt96,844
Total Debt/Equity0.03
Current Ratio3.97
Book Value Per Share1.14

Price History

52-Week Change-80.54
52-Week High3.31
52-Week Low0.42
Moving Average 50 Days0.66
Moving Average 200 Days1.23

Statistics

Average Volume234,333
Shares Outstanding4.74M
% Held by Institutions4.19

Dividend And Splits

Trailing Annual Dividend Rate0
Trailing Annual Dividend Yield0
Payout Ratio0
Last Split Factor1:20
Last Split DateJanuary 22, 2024